1/16
03:05 pm
gsk
GSK (NYSE:GSK) had its "hold" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Low
Report
GSK (NYSE:GSK) had its "hold" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
1/14
12:11 pm
gsk
GSK (NYSE:GSK) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
GSK (NYSE:GSK) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.
1/10
03:22 pm
gsk
Jefferies Reaffirms a Buy Rating on GSK plc (GSK) – Here's Why [Yahoo! Finance]
Low
Report
Jefferies Reaffirms a Buy Rating on GSK plc (GSK) – Here's Why [Yahoo! Finance]
1/6
12:00 pm
gsk
GSK (NYSE:GSK) was downgraded by analysts at Barclays PLC from an "equal weight" rating to an "underweight" rating.
Low
Report
GSK (NYSE:GSK) was downgraded by analysts at Barclays PLC from an "equal weight" rating to an "underweight" rating.
12/30
12:17 am
gsk
Why is GSK plc (GSK) One of the Best Affordable Healthcare Stocks to Buy Now? [Yahoo! Finance]
Neutral
Report
Why is GSK plc (GSK) One of the Best Affordable Healthcare Stocks to Buy Now? [Yahoo! Finance]
12/29
04:41 am
gsk
HSBC Sees Pharma Poised to Outperform in 2026, Lifts GSK Target [Yahoo! Finance]
Low
Report
HSBC Sees Pharma Poised to Outperform in 2026, Lifts GSK Target [Yahoo! Finance]
12/21
05:43 pm
gsk
Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSK
Low
Report
Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSK
12/16
09:55 pm
gsk
Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma
Low
Report
Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma
12/12
07:43 am
gsk
GSK (GSK) Scores Win in the Form of Lung Cancer Drug's Orphan Drug Designation [Yahoo! Finance]
Low
Report
GSK (GSK) Scores Win in the Form of Lung Cancer Drug's Orphan Drug Designation [Yahoo! Finance]
12/10
07:21 am
gsk
GSK (NYSE:GSK) had its "reduce" rating reaffirmed by analysts at HSBC Holdings plc.
Low
Report
GSK (NYSE:GSK) had its "reduce" rating reaffirmed by analysts at HSBC Holdings plc.
11/27
02:48 pm
gsk
GSK (NYSE:GSK) had its "buy (b)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
GSK (NYSE:GSK) had its "buy (b)" rating reaffirmed by analysts at
Weiss Ratings.
11/25
08:45 am
gsk
GSK (NYSE:GSK) was upgraded by analysts at Bank of America Corporation from an "underperform" rating to a "neutral" rating.
Low
Report
GSK (NYSE:GSK) was upgraded by analysts at Bank of America Corporation from an "underperform" rating to a "neutral" rating.
11/21
01:59 pm
gsk
GSK (NYSE:GSK) had its "buy (b)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
GSK (NYSE:GSK) had its "buy (b)" rating reaffirmed by analysts at
Weiss Ratings.
11/11
10:10 pm
gsk
Deutsche Bank Maintains a Hold Rating on GSK plc (GSK) [Yahoo! Finance]
Low
Report
Deutsche Bank Maintains a Hold Rating on GSK plc (GSK) [Yahoo! Finance]
10/31
01:03 pm
gsk
GSK (NYSE:GSK) was upgraded by analysts at
Weiss Ratings from a "hold (c+)" rating to a "buy (b-)" rating.
Low
Report
GSK (NYSE:GSK) was upgraded by analysts at
Weiss Ratings from a "hold (c+)" rating to a "buy (b-)" rating.
10/30
12:03 pm
gsk
GSK (NYSE:GSK) was given a new $53.00 price target on by analysts at Cfra.
Low
Report
GSK (NYSE:GSK) was given a new $53.00 price target on by analysts at Cfra.
10/27
08:06 am
gsk
GSK (NYSE:GSK) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Low
Report
GSK (NYSE:GSK) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
10/23
08:11 pm
gsk
Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma
Low
Report
Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma